The Chase Group is pleased to announce their continued partnership with Atsena Therapeutics after being retained to execute a search for an Associate Director/Director of… Continue Reading →
As part of its growth strategy, Arcturus Therapeutics has partnered with The Chase Group to build and expand their vaccines development team. Founded in 2013… Continue Reading →
Alexza Pharmaceuticals continues to partner with The Chase Group to secure a Senior Director/Head, Quality Assurance. The Chase Group is currently seeking quality assurance professionals… Continue Reading →
Atsena Therapeutics has retained The Chase Group to identify a Head of Regulatory. Chase is proud to partner with this clinical-stage ocular gene therapy company… Continue Reading →
Ventria Bioscience has partnered once again with The Chase Group to continue building their leadership team as they develop and commercialize innovative medicines with an… Continue Reading →
The Chase Group’s successful partnership with Alexza Pharmaceuticals has extended to include their parent company, Ferrer. A privately held company based in Barcelona, Spain, Ferrer… Continue Reading →
Alexza Pharmaceuticals, backed by their parent company, Ferrer, is working to develop products for the acute treatment of underserved medical needs in neuroscience. The company… Continue Reading →
Arcturus Therapeutics is a growing company with a versatile portfolio and cutting-edge mRNA technology that can be adapted to multiple disease areas. New to clinical… Continue Reading →
The combination of expertise and passion to build transformative, life-changing medicines for patients and their families positions Arcturus Therapeutics to catalyze the next generation of… Continue Reading →
Akcea Therapeutics is focused on helping patients living with rare diseases by understanding patient and physician needs by bringing transformative medicines to market. Akcea is… Continue Reading →